58. Hypertrophic cardiomyopathy Clinical trials / Disease details
Clinical trials : 126 / Drugs : 135 - (DrugBank : 42) / Drug target genes : 46 - Drug target pathways : 162
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05073094 (ClinicalTrials.gov) | October 6, 2021 | 19/5/2021 | Esmolol for Myocardial Protection in Hypertrophic Obstructive Cardiomyopathy | Myocardial Protection With Esmolol in Patients With Hypertrophic Obstructive Cardiomyopathy Undergoing Surgery Under Cardiopulmonary Bypass | Hypertrophic Obstructive Cardiomyopathy | Drug: Esmolol;Drug: Placebo | Meshalkin Research Institute of Pathology of Circulation | NULL | Recruiting | 18 Years | N/A | All | 80 | Phase 4 | Russian Federation |